185 related articles for article (PubMed ID: 29731372)
1. [Inhaled chemotherapy - Part 1: General concept and current technological challenges].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):357-377. PubMed ID: 29731372
[TBL] [Abstract][Full Text] [Related]
2. [Inhaled chemotherapy - Part 2: Clinical practice and potential applications].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):378-389. PubMed ID: 29731374
[TBL] [Abstract][Full Text] [Related]
3. Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects.
Wauthoz N; Rosière R; Amighi K
Expert Opin Drug Deliv; 2021 Mar; 18(3):333-354. PubMed ID: 33050733
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.
Mangal S; Gao W; Li T; Zhou QT
Acta Pharmacol Sin; 2017 Jun; 38(6):782-797. PubMed ID: 28504252
[TBL] [Abstract][Full Text] [Related]
5. Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers.
Islam N; Richard D
Curr Cancer Drug Targets; 2019; 19(3):162-178. PubMed ID: 29793407
[TBL] [Abstract][Full Text] [Related]
6. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
Okuda T; Okamoto H
Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
[TBL] [Abstract][Full Text] [Related]
7. Inhaled chemotherapy in lung cancer: future concept of nanomedicine.
Zarogoulidis P; Chatzaki E; Porpodis K; Domvri K; Hohenforst-Schmidt W; Goldberg EP; Karamanos N; Zarogoulidis K
Int J Nanomedicine; 2012; 7():1551-72. PubMed ID: 22619512
[TBL] [Abstract][Full Text] [Related]
8. Aerosolized chemotherapy.
Gagnadoux F; Hureaux J; Vecellio L; Urban T; Le Pape A; Valo I; Montharu J; Leblond V; Boisdron-Celle M; Lerondel S; Majoral C; Diot P; Racineux JL; Lemarie E
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):61-70. PubMed ID: 18518832
[TBL] [Abstract][Full Text] [Related]
9. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
10. How can we bring high drug doses to the lung?
Claus S; Weiler C; Schiewe J; Friess W
Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
[TBL] [Abstract][Full Text] [Related]
11. How Should Aerosols Be Delivered During Invasive Mechanical Ventilation?
Dhand R
Respir Care; 2017 Oct; 62(10):1343-1367. PubMed ID: 28874611
[TBL] [Abstract][Full Text] [Related]
12. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
Muralidharan P; Hayes D; Mansour HM
Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
[TBL] [Abstract][Full Text] [Related]
13. Formulation techniques for high dose dry powders.
Brunaugh AD; Smyth HDC
Int J Pharm; 2018 Aug; 547(1-2):489-498. PubMed ID: 29778822
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary drug delivery by powder aerosols.
Yang MY; Chan JG; Chan HK
J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
[TBL] [Abstract][Full Text] [Related]
15. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
Kolanjiyil AV; Kleinstreuer C; Sadikot RT
Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
[TBL] [Abstract][Full Text] [Related]
16. Challenges and Successes Using Nanomedicines for Aerosol Delivery to the Airways.
Resnier P; Mottais A; Sibiril Y; Le Gall T; Montier T
Curr Gene Ther; 2016; 16(1):34-46. PubMed ID: 26725879
[TBL] [Abstract][Full Text] [Related]
17. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
18. Aerosol Delivery Devices for Obstructive Lung Diseases.
Pleasants RA; Hess DR
Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
[TBL] [Abstract][Full Text] [Related]
19. Aerosol Delivery in the Treatment of Lung Cancer.
Storti C; Le Noci V; Sommariva M; Tagliabue E; Balsari A; Sfondrini L
Curr Cancer Drug Targets; 2015; 15(7):604-12. PubMed ID: 26033086
[TBL] [Abstract][Full Text] [Related]
20. Inhaled formulations and pulmonary drug delivery systems for respiratory infections.
Zhou QT; Leung SS; Tang P; Parumasivam T; Loh ZH; Chan HK
Adv Drug Deliv Rev; 2015 May; 85():83-99. PubMed ID: 25451137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
